The observations from this study can be further subjected to in vivo and/or in vitro studies to not only elucidate the pathophysiology of ALS8 caused by VAPB MSP domain pathogenic variants but also develop novel therapeutics for the disorder that restore the native fluctuations and motions. This evidence concerns the gene VAPB and amyotrophic lateral sclerosis type 8.